Vaccines in oncology: background and clinical potential

被引：7

作者：

Armstrong, AC ^{[1
]}

Hawkins, RE

机构：

[1] Univ Manchester, CRC, Dept Med Oncol, Manchester M20 4BX, Lancs, England

[2] Christie Hosp NHS Trust, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England

来源：

BRITISH JOURNAL OF RADIOLOGY | 2001年 / 74卷 / 887期

关键词：

D O I：

10.1259/bjr.74.887.740991

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Cancer is one of the leading causes of death in Western society. Despite improvements in screening, diagnosis and treatment of cancer, many patients ultimately succumb to their disease. Advances in molecular biology and our increased understanding of how the immune system functions have led to an intense interest in the development of cancer vaccines.

引用

页码：991 / 1002

页数：12

共 83 条

[1] MELANOMA-CELLS AND NORMAL MELANOCYTES SHARE ANTIGENS RECOGNIZED BY HLA-A2-RESTRICTED CYTOTOXIC T-CELL CLONES FROM MELANOMA PATIENTS [J].

ANICHINI, A ;

MACCALLI, C ;

MORTARINI, R ;

SALVI, S ;

MAZZOCCHI, A ;

SQUARCINA, P ;

HERLYN, M ;

PARMIANI, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :989-998

[2]

Arthur JF, 1997, CANCER GENE THER, V4, P17

[3]

AUSTYN JM, 1994, J IMMUNOL, V152, P2401

[4] SPONTANEOUS REGRESSION OF SUBCUTANEOUS METASTASIS OF CUTANEOUS MELANOMA [J].

BALDO, M ;

SCHIAVON, M ;

CICOGNA, PA ;

BOCCATO, P ;

MAZZOLENI, F .

PLASTIC AND RECONSTRUCTIVE SURGERY, 1992, 90 (06) :1073-1076

[5] Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma [J].

Bendandi, M ;

Gocke, CD ;

Kobrin, CB ;

Benko, FA ;

Sternas, LA ;

Pennington, R ;

Watson, TM ;

Reynolds, CW ;

Gause, BL ;

Duffey, PL ;

Jaffe, ES ;

Creekmore, SP ;

Longo, DL ;

Kwak, LW .

NATURE MEDICINE, 1999, 5 (10) :1171-1177

[6] TREATMENT OF METASTATIC MELANOMA WITH AN AUTOLOGOUS TUMOR-CELL VACCINE - CLINICAL AND IMMUNOLOGICAL RESULTS IN 64 PATIENTS [J].

BERD, D ;

MAGUIRE, HC ;

MCCUE, P ;

MASTRANGELO, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (11) :1858-1867

[7]

BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.iy.12.040194.002005

[8] A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer [J].

Borysiewicz, LK ;

Fiander, A ;

Nimako, M ;

Man, S ;

Wilkinson, GWG ;

Westmoreland, D ;

Evans, AS ;

Adams, M ;

Stacey, SN ;

Boursnell, MEG ;

Rutherford, E ;

Hickling, JK ;

Inglis, SC .

LANCET, 1996, 347 (9014) :1523-1527

[9] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].

BOSCH, FX ;

MANOS, MM ;

MUNOZ, N ;

SHERMAN, M ;

JANSEN, AM ;

PETO, J ;

SCHIFFMAN, MH ;

MORENO, V ;

KURMAN, R ;

SHAH, KV ;

ALIHONOU, E ;

BAYO, S ;

MOKHTAR, HC ;

CHICAREON, S ;

DAUDT, A ;

DELOSRIOS, E ;

GHADIRIAN, P ;

KITINYA, JN ;

KOULIBALY, M ;

NGELANGEL, C ;

TINTORE, LMP ;

RIOSDALENZ, JL ;

SARJADI ;

SCHNEIDER, A ;

TAFUR, L ;

TEYSSIE, AR ;

ROLON, PA ;

TORROELLA, M ;

TAPIA, AV ;

WABINGA, HR ;

ZATONSKI, W ;

SYLLA, B ;

VIZCAINO, P ;

MAGNIN, D ;

KALDOR, J ;

GREER, C ;

WHEELER, C .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802

[10] HUMAN GENE MAGE-1, WHICH CODES FOR A TUMOR-REJECTION ANTIGEN, IS EXPRESSED BY SOME BREAST-TUMORS [J].

BRASSEUR, F ;

MARCHAND, M ;

VANWIJCK, R ;

HERIN, M ;

LETHE, B ;

CHOMEZ, P ;

BOON, T .

INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (05) :839-841

← 1 2 3 4 5 6 7 8 9 →